Small Bowel Evaluation Using Novel Motorized Spiral Enteroscopy

NCT ID: NCT04959994

Last Updated: 2022-05-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-06-15

Study Completion Date

2022-06-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Small bowel evaluation using Novel Motorized Spiral Enteroscopy - Prospective non-controlled clinical study from a single tertiary care centre.

Data regarding the safety and efficacy of Novel Motorized Spiral Enteroscopy in the evaluation of the small bowel, most of them are retrospective. This study is being planned to collect the data prospectively for all the patients undergoing this procedure at our center including the follow up at 1 month for any adverse events.This will enlighten us in understanding the role of Novel Motorized Spiral in the evaluation of the small bowel Enteroscopy in the small bowel evaluation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

1. Introduction Few studies have been published till now regarding the safety and efficacy of Novel Motorized Spiral Enteroscopy in the evaluation of the small bowel, most of them are retrospective. This study is being planned to collect the data prospectively for all the patients undergoing this procedure at our centre including the follow up at 1 month for any adverse events. This will help us to develop our understanding the role of Novel Motorized Spiral Enteroscopy in the small bowel evaluation.
2. Rationale Prospective study evaluating the efficacy of the Novel Motorized Spiral Enteroscopy is lacking. This study will help in understanding the efficacy and safety of the procedure in the evaluation of the small bowel diseases.
3. Study Population All the patients who will undergo small bowel evaluation using Novel Motorized Spiral Enteroscopy at AIG Hospitals, Gachibowli, Hyderabad, Telangana, India
4. Methodology Patients with suspected small bowel disease with an indication for total enteroscopy will undergo Novel Motorized Spiral Enteroscopy at AIG hospitals. Patient record including the Demographic details, Indications, Pre-Anaesthesia evaluation, History of any previous surgery or prior enteroscopy. Procedure technical success, Total enteroscopic small bowel evaluation rate or extent of examination. Therapeutic procedure underwent, Total Procedure time, Diagnosis, Recovery from anaesthesia time record will be maintained. All the patients will be followed up telephonically for any possible adverse event upto 30 days.

Patient details will be recorded in a proforma after taking proper informed consent.

4a. Inclusion Criteria

1. Patients with small bowel disease with an indication for Motorized spiral enteroscopy
2. Overt or obscure Gastrointestinal bleeding
3. Iron deficiency anaemia
4. Chronic diarrhoea
5. Abdominal pain for evaluation with suspected small bowel involvement.
6. IBD requiring small bowel evaluation
7. Polyposis syndrome requiring small bowel evaluation
8. Small bowel subacute obstruction
9. Refractory celiac disease

4b. Exclusion criteria

1. Weight less than 30 kg
2. Large gastric or oesophageal varices
3. Any medical contraindication to standard enteroscopy
4. Any prior history of gastric , small bowel , large bowel surgery
5. Acute obstruction of small bowel
6. Suspected GI perforation
7. Any contraindication for general anaesthesia
8. Lack of informed consent.

4c. Subject recruitment All the patients who will undergo the procedure according to the inclusion and exclusion criteria will be taken. Prospectively their records will be maintained by proforma at AIG hospitals, Gachibowli.

4d. Randomization and blinding - NIL Single group assignment with no randomization

4e. Method of assessment This will be a non- controlled single group assignment study,All antegrade power spiral enteroscopy procedures will be performed under elective general anesthesia with nasotracheal intubation.Retrograde power spiral enteroscopy procedures will be performed under deep sedation using propofol.A prophylactic wire guided dilatation using Savary - Gilliard dilator up to 20 mm will be done in all the patients. After the maximal depth of insertion via the antegrade route hemoclip or Indiaink will be applied to mark the maximal depth of insertion and retrograde enteroscopy will be done to try to trace the hemoclip on the same or the next day to obtain total enteroscopy.

4f. Stopping or discontinuation criteria- None

5\. Sample size calculation All the patients who will undergo Novel Motorized Spiral Enteroscopy will be recorded in a proforma and their follow up at 30 days will be assessed telephonically for a duration of 1 year

6\. Statistical analysis The database will be created with Microsoft Excel (Microsoft, Seattle, Wash, USA). Data entry will be done by primary investigator using google forms and it will be stored with the primary investigator. Statistical analyses will be done using SPSS version 25 (IBM Corp., Armonk, NY, USA). Continuous measures will be expressed with sample size, mean (standard deviation), median (range), as and when required. Categorical measures will be presented as number of patients and percentage. The 95% confidence interval will be calculated using exact Clopper-Pearson for diagnostic yield and TER.

7\. Ethical justification of the study This is a prospective nonrandomized non-controlled trial with patients not assigned to any specific intervention.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Small Bowel Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Novel Motorized Spiral Enteroscopy

All the patients with suspected small bowel disease and an indication to undergo total enteroscopy and satisfying inclusion criteria will undergo novel motorized spiral enteroscopy

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients with small bowel disease with an indication for Motorized spiral enteroscopy and age more than 10 years
2. Overt or obscure Gastrointestinal bleeding
3. Iron deficiency anaemia
4. Chronic diarrhoea
5. Abdominal pain for evaluation with suspected small bowel involvement.
6. IBD requiring small bowel evaluation
7. Polyposis syndrome requiring small bowel evaluation
8. Small bowel subacute obstruction
9. Refractory celiac disease

Exclusion Criteria

1. Weight less than 30 kg
2. Large gastric or oesophageal varices
3. Any medical contraindication to standard enteroscopy
4. Any prior history of gastric , small bowel , large bowel surgery
5. Acute obstruction of small bowel
6. Suspected GI perforation
7. Any contraindication for general anaesthesia
8. Lack of informed consent.
Minimum Eligible Age

10 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Asian Institute of Gastroenterology, India

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Aniruddha P Singh, MBBS,MD,DM

Role: PRINCIPAL_INVESTIGATOR

AIG hospitals,India

Mohan Ramchandani, MBBS,MD,DM

Role: STUDY_DIRECTOR

AIG Hospitals,India

Duvur Nageshwar Reddy

Role: STUDY_CHAIR

AIG Hospitals,India

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Aniruddha Pratap Singh

Hyderabad, Telangana, India

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

India

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Aniruddha P Singh, MBBS,MD,DM

Role: CONTACT

09004093248

Mohan Ramchandani, MBBS,MD,DM

Role: CONTACT

+919701335444

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Aniruddha P Singh, MBBS,MD,DM

Role: primary

09004093248

References

Explore related publications, articles, or registry entries linked to this study.

Beyna T, Arvanitakis M, Schneider M, Gerges C, Hoellerich J, Deviere J, Neuhaus H. Total motorized spiral enteroscopy: first prospective clinical feasibility trial. Gastrointest Endosc. 2021 Jun;93(6):1362-1370. doi: 10.1016/j.gie.2020.10.028. Epub 2020 Nov 2.

Reference Type RESULT
PMID: 33144239 (View on PubMed)

Beyna T, Arvanitakis M, Schneider M, Gerges C, Boing D, Deviere J, Neuhaus H. Motorised spiral enteroscopy: first prospective clinical feasibility study. Gut. 2021 Feb;70(2):261-267. doi: 10.1136/gutjnl-2019-319908. Epub 2020 Apr 24.

Reference Type RESULT
PMID: 32332141 (View on PubMed)

Ramchandani M, Rughwani H, Inavolu P, Singh AP, Tevethia HV, Jagtap N, Sekaran A, Kanakagiri H, Darishetty S, Reddy DN. Diagnostic yield and therapeutic impact of novel motorized spiral enteroscopy in small-bowel disorders: a single-center, real-world experience from a tertiary care hospital (with video). Gastrointest Endosc. 2021 Mar;93(3):616-626. doi: 10.1016/j.gie.2020.07.001. Epub 2020 Jul 12.

Reference Type RESULT
PMID: 32663489 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AIG/IEC-BH&R 15/06.2021-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.